Caxton Associates (UK)’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.08M Buy
+21,519
New +$2.21M 0.05% 207
2025
Q2
Sell
-2,561
Closed -$259K 743
2025
Q1
$259K Buy
+2,561
New +$250K 0.01% 659

Other funds holding EHC

Caxton Associates (UK)'s EHC Position: Q1 2026 in Review

Caxton Associates (UK) opened a new position in Encompass Health (EHC) in Q1 2026: 21,519 shares worth $2.08M. The stake represents 0.05% of the portfolio and ranks #207 among its holdings. This is a return to the name: Caxton Associates (UK) previously reported a position in EHC as recently as Q1 2025.

Caxton Associates (UK) first reported a position in EHC in Q1 2025 and has held it in 2 quarters since. 577 funds tracked by Wall St. Rank hold EHC as of Q1 2026.

  • Caxton Associates (UK) held 21,519 shares of Encompass Health worth $2.08M as of Q1 2026.
  • Encompass Health was a new Caxton Associates (UK) position in Q1 2026.
  • Encompass Health made up 0.05% of Caxton Associates (UK)'s portfolio in Q1 2026, its #207 holding.
  • Caxton Associates (UK) first reported a position in Encompass Health in Q1 2025 and has held it in 2 quarters since.
  • 577 funds tracked by Wall St. Rank held Encompass Health as of Q1 2026.

Based on Caxton Associates (UK)'s 13F filing for Q1 2026, filed 14 May 2026.